ELI LILLY AND COMPANY Revenue
ELI LILLY AND COMPANY (LLY) reported Revenue of $22.97 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-05
- ELI LILLY AND COMPANY revenues for the quarter ending 2026-06-30 was $22.97B, a 47.67% increase year-over-year.
- ELI LILLY AND COMPANY revenues for the quarter ending 2026-03-31 was $19.80B, a 55.54% increase year-over-year.
- ELI LILLY AND COMPANY revenues for the quarter ending 2025-12-31 was $19.29B, a 42.55% increase year-over-year.
- ELI LILLY AND COMPANY revenues for the quarter ending 2025-09-30 was $17.60B, a 53.87% increase year-over-year.
- ELI LILLY AND COMPANY revenues for fiscal 2025 was $65.18B, a 44.70% increase from fiscal 2024.
- ELI LILLY AND COMPANY revenues for fiscal 2024 was $45.04B, a 32.00% increase from fiscal 2023.
- ELI LILLY AND COMPANY revenues for fiscal 2023 was $34.12B, a 19.56% increase from fiscal 2022.
- ELI LILLY AND COMPANY revenues for fiscal 2022 was $28.54B, a 0.79% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.97B 10-Q · filed 2026-08-05 | $42.77B 10-Q · filed 2026-08-05 | $62.06B derived: sum of 3 quarters · filed 2026-08-05 | $79.67B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $19.80B 10-Q · filed 2026-04-30 | $39.09B derived: sum of 2 quarters · filed 2026-04-30 | $56.69B derived: sum of 3 quarters · filed 2026-04-30 | $72.25B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $19.29B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $36.89B derived: sum of 2 quarters · filed 2026-02-12 | $52.45B derived: sum of 3 quarters · filed 2026-08-05 | $65.18B 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $17.60B 10-Q · filed 2025-10-30 | $33.16B derived: sum of 2 quarters · filed 2026-08-05 | $45.89B 10-Q · filed 2025-10-30 | $59.42B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $15.56B 10-Q · filed 2026-08-05 | $15.56B 10-Q · filed 2025-08-07 | $28.29B 10-Q · filed 2026-08-05 | $28.29B 10-Q · filed 2025-08-07 | $41.82B derived: sum of 3 quarters · filed 2026-08-05 | $53.26B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $12.73B 10-Q · filed 2026-04-30 | $12.73B 10-Q · filed 2025-05-01 | $26.26B derived: sum of 2 quarters · filed 2026-04-30 | $37.70B derived: sum of 3 quarters · filed 2026-04-30 | $49.00B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $13.53B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $24.97B derived: sum of 2 quarters · filed 2026-02-12 | $36.27B derived: sum of 3 quarters · filed 2026-02-12 | $45.04B 10-K · filed 2026-02-12 | $45.04B 10-K · filed 2025-02-19 | |||
| 2024-09-30 | $11.44B 10-Q · filed 2025-10-30 | $22.74B derived: sum of 2 quarters · filed 2025-10-30 | $31.51B 10-Q · filed 2025-10-30 | $40.86B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $11.30B 10-Q · filed 2025-08-07 | $20.07B 10-Q · filed 2025-08-07 | $29.42B derived: sum of 3 quarters · filed 2026-02-12 | $38.92B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $8.77B 10-Q · filed 2025-05-01 | $18.12B derived: sum of 2 quarters · filed 2026-02-12 | $27.62B derived: sum of 3 quarters · filed 2026-02-12 | $35.93B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $9.35B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $18.85B derived: sum of 2 quarters · filed 2026-02-12 | $27.16B derived: sum of 3 quarters · filed 2026-02-12 | $34.12B 10-K · filed 2026-02-12 | $34.12B 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $9.50B 10-Q · filed 2024-10-30 | $17.81B derived: sum of 2 quarters · filed 2024-10-30 | $24.77B 10-Q · filed 2024-10-30 | $32.07B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | $8.31B 10-Q · filed 2024-08-08 | $15.27B 10-Q · filed 2024-08-08 | $22.57B derived: sum of 3 quarters · filed 2025-02-19 | $29.52B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | $6.96B 10-Q · filed 2024-04-30 | $14.26B derived: sum of 2 quarters · filed 2025-02-19 | $21.20B derived: sum of 3 quarters · filed 2025-02-19 | $27.69B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $7.30B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $14.24B derived: sum of 2 quarters · filed 2025-02-19 | $20.73B derived: sum of 3 quarters · filed 2025-02-19 | $28.54B 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | $6.94B 10-Q · filed 2023-11-02 | $13.43B derived: sum of 2 quarters · filed 2023-11-02 | $21.24B 10-Q · filed 2023-11-02 | $29.24B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $6.49B 10-Q · filed 2023-08-08 | $14.30B 10-Q · filed 2023-08-08 | $22.30B derived: sum of 3 quarters · filed 2024-02-21 | $29.07B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $7.81B 10-Q · filed 2023-04-27 | $15.81B derived: sum of 2 quarters · filed 2024-02-21 | $22.58B derived: sum of 3 quarters · filed 2024-02-21 | $29.32B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $8.00B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $14.77B derived: sum of 2 quarters · filed 2024-02-21 | $21.51B derived: sum of 3 quarters · filed 2024-02-21 | $28.32B 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $6.77B 10-Q · filed 2022-11-01 | $13.51B derived: sum of 2 quarters · filed 2022-11-01 | $20.32B 10-Q · filed 2022-11-01 | $27.76B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $6.74B 10-Q · filed 2022-08-04 | $13.55B 10-Q · filed 2022-08-04 | $20.99B derived: sum of 3 quarters · filed 2023-02-22 | $26.73B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $6.81B 10-Q · filed 2022-04-29 | $14.25B derived: sum of 2 quarters · filed 2023-02-22 | $19.99B derived: sum of 3 quarters · filed 2023-02-22 | $25.49B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $7.44B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $13.18B derived: sum of 2 quarters · filed 2023-02-22 | $18.68B derived: sum of 3 quarters · filed 2023-02-22 | $24.54B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $5.74B 10-Q · filed 2021-10-27 | $11.24B derived: sum of 2 quarters · filed 2021-10-27 | $17.10B 10-Q · filed 2021-10-27 | $23.21B derived: sum of 4 quarters · filed 2021-10-27 | ||||
| 2020-06-30 | $5.50B 10-Q · filed 2021-08-03 | $11.36B 10-Q · filed 2021-08-03 | $17.47B derived: sum of 3 quarters · filed 2021-08-03 | $22.95B derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $5.86B 10-Q · filed 2021-04-30 | $11.97B derived: sum of 2 quarters · filed 2021-04-30 | $17.45B derived: sum of 3 quarters · filed 2021-04-30 | $23.09B derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $6.11B 10-K · filed 2020-02-19 | $11.59B derived: sum of 2 quarters · filed 2020-10-28 | $17.23B derived: sum of 3 quarters · filed 2020-10-28 | $22.32B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $5.48B 10-Q · filed 2020-10-28 | $11.11B derived: sum of 2 quarters · filed 2020-10-28 | $16.21B 10-Q · filed 2020-10-28 | $21.84B derived: sum of 4 quarters · filed 2020-10-28 | ||||
| 2019-06-30 | $5.64B 10-Q · filed 2020-07-31 | $10.73B 10-Q · filed 2020-07-31 | $16.37B derived: sum of 3 quarters · filed 2020-07-31 | $21.67B derived: sum of 4 quarters · filed 2020-07-31 | ||||
| 2019-03-31 | $5.09B 10-Q · filed 2020-05-01 | $10.73B derived: sum of 2 quarters · filed 2020-05-01 | $16.04B derived: sum of 3 quarters · filed 2020-05-01 | $21.62B derived: sum of 4 quarters · filed 2020-05-01 | ||||
| 2018-12-31 | $5.64B 10-K · filed 2020-02-19 | $6.44B 10-K · filed 2019-02-19 | $10.94B derived: sum of 2 quarters · filed 2020-02-19 | $16.53B derived: sum of 3 quarters · filed 2020-02-19 | $21.49B 10-K · filed 2021-02-17 | $24.56B 10-K · filed 2019-02-19 | ||
| 2018-09-30 | $5.31B 10-K · filed 2020-02-19 | $6.06B 10-Q · filed 2018-11-06 | $10.89B derived: sum of 2 quarters · filed 2020-02-19 | $15.86B 10-Q · filed 2019-10-25 | $18.12B 10-Q · filed 2018-11-06 | $21.26B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-06-30 | $5.58B 10-K · filed 2020-02-19 | $6.36B 10-Q · filed 2018-07-25 | $10.55B 10-Q · filed 2019-08-02 | $12.06B 10-Q · filed 2018-07-25 | $15.96B derived: sum of 3 quarters · filed 2020-02-19 | $20.92B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $4.96B 10-K · filed 2020-02-19 | $5.70B 10-Q · filed 2018-04-27 | $10.37B derived: sum of 2 quarters · filed 2020-02-19 | $15.33B derived: sum of 3 quarters · filed 2020-02-19 | $20.42B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $5.41B 8-K · filed 2019-10-24 | $6.16B 10-K · filed 2018-02-20 | $10.37B derived: sum of 2 quarters · filed 2019-10-24 | $15.46B derived: sum of 3 quarters · filed 2019-10-24 | $19.97B 10-K · filed 2020-02-19 | $22.87B 10-K · filed 2018-02-20 | ||
| 2017-09-30 | $4.96B 8-K · filed 2019-10-24 | $5.66B 10-Q · filed 2017-10-27 | $10.05B derived: sum of 2 quarters · filed 2019-10-24 | $16.71B 10-Q · filed 2018-11-06 | $20.33B derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-06-30 | $5.09B 8-K · filed 2019-10-24 | $5.82B 10-Q · filed 2017-07-28 | $11.05B 10-Q · filed 2018-07-25 | $15.37B derived: sum of 3 quarters · filed 2019-10-24 | $20.56B derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-03-31 | $4.51B 8-K · filed 2019-10-24 | $5.23B 10-Q · filed 2017-05-01 | $10.28B derived: sum of 2 quarters · filed 2019-10-24 | $15.47B derived: sum of 3 quarters · filed 2019-10-24 | $20.87B derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2016-12-31 | $5.76B 10-K · filed 2018-02-20 | $10.95B derived: sum of 2 quarters · filed 2018-02-20 | $16.36B derived: sum of 3 quarters · filed 2018-02-20 | $18.31B 8-K · filed 2019-10-24 | $21.22B 10-K · filed 2017-02-21 | |||
| 2016-09-30 | $5.19B 10-K · filed 2018-02-20 | $10.60B derived: sum of 2 quarters · filed 2018-02-20 | $15.46B 10-Q · filed 2017-10-27 | $20.84B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-06-30 | $5.40B 10-K · filed 2018-02-20 | $10.27B 10-Q · filed 2017-07-28 | $15.65B derived: sum of 3 quarters · filed 2018-02-20 | $20.61B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-03-31 | $4.87B 10-K · filed 2018-02-20 | $10.24B derived: sum of 2 quarters · filed 2018-02-20 | $15.20B derived: sum of 3 quarters · filed 2018-02-20 | $20.18B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2015-12-31 | $5.38B 10-K · filed 2017-02-21 | $10.34B derived: sum of 2 quarters · filed 2017-02-21 | $15.31B derived: sum of 3 quarters · filed 2017-02-21 | $19.96B 10-K · filed 2018-02-20 | ||||
| 2015-09-30 | $4.96B 10-K · filed 2017-02-21 | $9.94B derived: sum of 2 quarters · filed 2017-02-21 | $14.58B 10-Q · filed 2016-10-28 | $19.70B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | $4.98B 10-K · filed 2017-02-21 | $9.62B 10-Q · filed 2016-07-28 | $14.74B derived: sum of 3 quarters · filed 2017-02-21 | $19.62B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $4.64B 10-K · filed 2017-02-21 | $9.77B derived: sum of 2 quarters · filed 2017-02-21 | $14.64B derived: sum of 3 quarters · filed 2017-02-21 | $19.58B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $5.12B 10-K · filed 2016-02-19 | $10.00B derived: sum of 2 quarters · filed 2016-02-19 | $14.93B derived: sum of 3 quarters · filed 2016-02-19 | $19.62B 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $4.88B 10-K · filed 2016-02-19 | $9.81B derived: sum of 2 quarters · filed 2016-02-19 | $14.49B 10-Q · filed 2015-10-30 | $20.30B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $4.94B 10-K · filed 2016-02-19 | $9.62B 10-Q · filed 2015-07-30 | $15.43B derived: sum of 3 quarters · filed 2016-02-19 | $21.20B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $4.68B 10-K · filed 2016-02-19 | $10.49B derived: sum of 2 quarters · filed 2016-02-19 | $16.26B derived: sum of 3 quarters · filed 2016-02-19 | $22.19B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $5.81B 10-K · filed 2015-02-19 | $11.58B derived: sum of 2 quarters · filed 2015-02-19 | $17.51B derived: sum of 3 quarters · filed 2015-02-19 | $23.11B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $5.77B 10-K · filed 2015-02-19 | $11.70B derived: sum of 2 quarters · filed 2015-02-19 | $17.30B 10-Q · filed 2014-10-29 | $23.26B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $5.93B 10-K · filed 2015-02-19 | $11.53B 10-Q · filed 2014-07-28 | $17.49B derived: sum of 3 quarters · filed 2015-02-19 | $22.93B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $5.60B 10-K · filed 2015-02-19 | $11.56B derived: sum of 2 quarters · filed 2015-02-19 | $17.00B derived: sum of 3 quarters · filed 2015-02-19 | $22.60B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $5.96B 10-K · filed 2014-02-19 | $11.40B derived: sum of 2 quarters · filed 2014-02-19 | $17.00B derived: sum of 3 quarters · filed 2014-02-19 | $22.60B 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $5.44B 10-K · filed 2014-02-19 | $11.04B derived: sum of 2 quarters · filed 2014-02-19 | $16.65B 10-Q · filed 2013-10-30 | $22.69B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-06-30 | $5.60B 10-K · filed 2014-02-19 | $11.20B 10-Q · filed 2013-07-26 | $17.25B derived: sum of 3 quarters · filed 2014-02-19 | $23.40B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-03-31 | $5.60B 10-K · filed 2014-02-19 | $11.65B derived: sum of 2 quarters · filed 2014-02-19 | $17.80B derived: sum of 3 quarters · filed 2014-02-19 | $24.05B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2011-12-31 | $6.05B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $12.19B derived: sum of 2 quarters · filed 2014-02-19 | $18.45B derived: sum of 3 quarters · filed 2014-02-19 | $24.29B 10-K · filed 2014-02-19 | ||||
| 2011-09-30 | $6.15B 10-Q · filed 2012-10-26 | $12.40B derived: sum of 2 quarters · filed 2012-10-26 | $18.24B 10-Q · filed 2012-10-26 | $24.43B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $6.25B 10-Q · filed 2012-07-27 | $12.09B 10-Q · filed 2012-07-27 | $18.28B derived: sum of 3 quarters · filed 2013-02-21 | $23.93B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $5.84B 10-Q · filed 2012-04-30 | $12.03B derived: sum of 2 quarters · filed 2013-02-21 | $17.68B derived: sum of 3 quarters · filed 2013-02-21 | $23.43B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $6.19B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $11.84B derived: sum of 2 quarters · filed 2013-02-21 | $17.59B derived: sum of 3 quarters · filed 2013-02-21 | $23.08B 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $5.65B 10-Q · filed 2011-10-28 | $11.40B derived: sum of 2 quarters · filed 2011-10-28 | $16.89B 10-Q · filed 2011-10-28 | $22.82B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-06-30 | $5.75B 10-Q · filed 2011-07-29 | $11.23B 10-Q · filed 2011-07-29 | $17.17B derived: sum of 3 quarters · filed 2012-02-24 | $22.73B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-03-31 | $5.49B 10-Q · filed 2011-04-29 | $11.42B derived: sum of 2 quarters · filed 2012-02-24 | $16.98B derived: sum of 3 quarters · filed 2012-02-24 | $22.27B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2009-12-31 | $5.93B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $11.50B derived: sum of 2 quarters · filed 2012-02-24 | $16.79B derived: sum of 3 quarters · filed 2012-02-24 | $21.84B 10-K · filed 2012-02-24 | ||||
| 2009-09-30 | $5.56B 10-Q · filed 2010-10-29 | $10.85B derived: sum of 2 quarters · filed 2010-10-29 | $15.90B 10-Q · filed 2010-10-29 | $21.11B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-06-30 | $5.29B 10-Q/A · filed 2010-08-02 | $10.34B 10-Q/A · filed 2010-08-02 | $15.54B derived: sum of 3 quarters · filed 2011-02-22 | $20.75B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-03-31 | $5.05B 10-Q · filed 2010-07-30 | $10.25B derived: sum of 2 quarters · filed 2011-02-22 | $15.46B derived: sum of 3 quarters · filed 2011-02-22 | $20.61B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2008-12-31 | $5.20B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $10.41B derived: sum of 2 quarters · filed 2011-02-22 | $15.56B derived: sum of 3 quarters · filed 2011-02-22 | $20.37B 10-K · filed 2011-02-22 | ||||
| 2008-09-30 | $5.21B 10-Q · filed 2009-10-30 | $10.36B derived: sum of 2 quarters · filed 2009-10-30 | $15.17B 10-Q · filed 2009-10-30 | |||||
| 2008-06-30 | $5.15B 10-Q · filed 2009-07-31 | $9.96B 10-Q · filed 2009-07-31 | ||||||
| 2007-12-31 | $18.63B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |